Saeeda Zaman Chowdhury, MD

Bhumika Patel, MD, is a Greenville native who has been in hematology and oncology practice since 2019. Dr. Patel received her medical degree from St. Matthews University School of Medicine in Grand Cayman, completed her residency at Prisma Health in Greenville and two fellowships at the Cleveland Clinic. She worked as a staff physician in the hematology and oncology department at the Cleveland Clinic from 2019–2022. She is board certified by the American Board of Internal Medicine, Oncology, and Hematology. Dr. Patel takes pride in delivering thorough and compassionate cancer care, striving to educate her patients about their disease, presenting them with all options, and empowering them to take an active role in their health in a family-oriented way. While proficient in all aspects of hematology, she has special interests in idiopathic cytopenia of undetermined significance, clonal hematopoiesis of indeterminate significance, clonal cytopenia of undetermined significance, aplastic anemia, PNH, telomere biology disorders, T-LGL, PRCA, MDS, MPN, acute leukemias, lymphomas and myeloma. She likes spending time with family and friends, traveling, watching movies, exercising and meditating, and enjoying music and the arts.

Elizabeth Cull, MD, is a physician specializing in medical oncology and hematology at Prisma Health Cancer Institute. She provides care and treatment for patients with benign and malignant blood disorders with emphasis on malignant disorders such as lymphoma, leukemia, and multiple myeloma including expertise in stem cell/bone marrow transplant. Dr. Cull earned her medical degree from Wake Forest University School of Medicine in Winston-Salem, NC. She completed her internship, residency and Hematology Oncology Fellowship at the McGraw Medical Center of Northwestern University in Chicago. Dr. Cull is board certified in both Medical Oncology and Hematology. She is a member of the American Society of Clinical Oncology, the American Society of Hematology and the American Society of Bone Marrow Transplant. Dr. Cull additionally manages the hematologic malignancy division of ITOR, the phase I clinical trial unit. She is also the co-director of the Adolescent and Young Adult Oncology program at Prisma Health.

Dr. Zurenko earned his M.D. at the State University of New York Upstate Medical Center in Syracuse. He completed his internship in Internal Medicine and his residency in Radiation Oncology at SUNY Upstate, as well as Syracuse. Dr. Zurenko is Board Certified by the American Board of Radiology in Radiation Oncology and is a Diplomate of the National Board of Medical Examiners.